ALFA Finder
11:01 IST
BSE
Board Meeting Date
Medicamen Biotech Board Meeting Date
Medicamen Biotech will meet on 13 Nov 2026 to consider half-yearly results for September 2026. Trading window stays closed from 01 Oct to 16 Nov 2026.
Medicamen Biotech Ltd
- Share price
- ₹275.45
- Market cap
- ₹387.4 Cr
- Revenue (annual)
- ₹197.8 Cr
- Net profit (annual)
- ₹9.64 Cr
- P/E (TTM)
- 35.8×Sector 43.8×
- Promoter holding
- 42.57%+2.11% QoQ
- FII holding
- 4.35%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Financial Results 4Other Announcement 3Board Meeting Date 3Annual General Meeting 3Preferential Issue 2Management Change 1Fund Raise 1Dividend 1Convertible Warrants 1Board Meeting Outcome 1
Time
3 announcements with these filters
14:57 IST
BSE
Board Meeting Date
Medicamen Biotech Board Meeting Date
Medicamen Biotech Limited has scheduled a board meeting for August 14, 2026. The board will consider unaudited financial results for the quarter ended June 30, 2026.
15:59 IST
BSE
Board Meeting Date
Medicamen Biotech Board Meeting Date
Medicamen Biotech scheduled a board meeting for May 27, 2026. Directors will consider FY26 audited financial results and recommend a final dividend for the year.